£225.00
Contents: 100 x 0.5mg Tablets
Note: Strictly for research purposes only. Not for human consumption
🔬 Product Overview
Tesofensine is a potent research compound originally studied for neurodegenerative disorders and later observed to have strong appetite-suppressing and weight-modulating effects. It is classed as a triple monoamine reuptake inhibitor and has shown promise in early-stage trials for supporting fat loss mechanisms.
This listing is for researchers and laboratories only. It is not intended for human use.
📦 What’s Included
⚗️ Research Interest & Observed Benefits (in Laboratory Settings)
💷 Why This Is a Long-Term Value
Other vendors typically offer just 30 tablets for £120+. Our 100-tablet research pack at £225 offers unmatched value and convenience for extended research:
⚠️ Important Notice
This product is sold strictly for laboratory research purposes. It is not intended for human consumption, therapeutic use, or dietary supplementation.
🔗 Tesofensine + Retatrutide in Research Settings
When co-administered in a research environment, Tesofensine may complement the effects of GLP-1 and GIP receptor agonists like Retatrutide by acting through alternative pathways:
This multi-targeted model is of interest in studies exploring long-term weight regulation, energy expenditure, and behavioural adherence in obese or insulin-resistant models.